CLASS IIDrug recall · Reported 2 Mar 2022 · FDA Enforcement Report
Severe Congestion Nasal Spray, No Drip Plus Menthol recalled
Perrigo is recalling Severe Congestion Nasal Spray, No Drip Plus Menthol, Oxymetazoline HCl 0.05% Nasal, distributed nationwide in the US. The recall was initiated on 26 Oct 2021 and the FDA has classified it as Class II.
Check your package
Lot, batch or date codesBatch: 1BK0827, Exp 12/31/2022
Quantity recalled3,168 bottles
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.
Reason for recall
CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.
Product as listed by the FDA
Severe Congestion Nasal Spray, No Drip Plus Menthol, Oxymetazoline HCl 0.05% Nasal Decongestant, 1 FL Oz (30 mL) per bottle, Packaged by Perrigo Company for: Big Lots Stores, Inc., P.O. Box 28523, Columbus, OH 43228-0523. NDC: 50594-719-10
CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.
Which lots are affected?
Batch: 1BK0827, Exp 12/31/2022
Where was it sold?
Nationwide in the USA
What should I do if I have it?
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
What does Class II mean?
Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.
Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.